The Colorado thyroid disease prevalence study.

CONTEXT The prevalence of abnormal thyroid function in the United States and the significance of thyroid dysfunction remain controversial. Systemic effects of abnormal thyroid function have not been fully delineated, particularly in cases of mild thyroid failure. Also, the relationship between traditional hypothyroid symptoms and biochemical thyroid function is unclear. OBJECTIVE To determine the prevalence of abnormal thyroid function and the relationship between (1) abnormal thyroid function and lipid levels and (2) abnormal thyroid function and symptoms using modern and sensitive thyroid tests. DESIGN Cross-sectional study. PARTICIPANTS Participants in a statewide health fair in Colorado, 1995 (N = 25 862). MAIN OUTCOME MEASURES Serum thyrotropin (thyroid-stimulating hormone [TSH]) and total thyroxine (T4) concentrations, serum lipid levels, and responses to a hypothyroid symptoms questionnaire. RESULTS The prevalence of elevated TSH levels (normal range, 0.3-5.1 mIU/L) in this population was 9.5%, and the prevalence of decreased TSH levels was 2.2%. Forty percent of patients taking thyroid medications had abnormal TSH levels. Lipid levels increased in a graded fashion as thyroid function declined. Also, the mean total cholesterol and low-density lipoprotein cholesterol levels of subjects with TSH values between 5.1 and 10 mIU/L were significantly greater than the corresponding mean lipid levels in euthyroid subjects. Symptoms were reported more often in hypothyroid vs euthyroid individuals, but individual symptom sensitivities were low. CONCLUSIONS The prevalence of abnormal biochemical thyroid function reported here is substantial and confirms previous reports in smaller populations. Among patients taking thyroid medication, only 60% were within the normal range of TSH. Modest elevations of TSH corresponded to changes in lipid levels that may affect cardiovascular health. Individual symptoms were not very sensitive, but patients who report multiple thyroid symptoms warrant serum thyroid testing. These results confirm that thyroid dysfunction is common, may often go undetected, and may be associated with adverse health outcomes that can be avoided by serum TSH measurement.

[1]  J. Franklyn,et al.  Thyroxine replacement therapy and circulating lipid concentrations , 1993, Clinical endocrinology.

[2]  P. Nilsson-ehle,et al.  Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations. , 1983, Acta endocrinologica.

[3]  H. Ikenoue,et al.  A Sensitive Thyroid Stimulating Hormone Assay for Screening of Thyroid Functional Disorder in Elderly Japanese , 1989, Journal of the American Geriatrics Society.

[4]  N. Farid,et al.  Serum lipids in hypothyroidism--a re-evaluation. , 1978, The Journal of clinical endocrinology and metabolism.

[5]  D. Cooper,et al.  L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. , 1984, Annals of internal medicine.

[6]  R. Hirsch,et al.  Yield of hypothyroidism in symptomatic primary care patients. , 1989, Archives of internal medicine.

[7]  F. Azizi,et al.  The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. , 1979, JAMA.

[8]  G. Daniels,et al.  The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. , 1990, The Journal of clinical endocrinology and metabolism.

[9]  J. Goodwin,et al.  Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. , 1987, JAMA.

[10]  C. Bloss,et al.  The Oklahoma State Department of Health Mobile Multiphasic Screening Program for Chronic Disease. II. , 1966, American journal of public health and the nation's health.

[11]  J. Nicoloff,et al.  Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. , 1990, The Journal of clinical endocrinology and metabolism.

[12]  Gavin La.  The diagnostic dilemmas of hyperthyroxinemia and hypothyroxinemia. , 1988 .

[13]  M. Friedman.  Screening for thyroid disease. , 1999, Annals of internal medicine.

[14]  Sidney H. Ingbar,et al.  The Thyroid Gland. , 1965 .

[15]  H. Stähelin,et al.  LDL/HDL‐CHANGES IN SUBCLINICAL HYPOTHYROIDISM: POSSIBLE RISK FACTORS FOR CORONARY HEART DISEASE , 1988, Clinical endocrinology.

[16]  L. Kuller,et al.  SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN , 1986, The Lancet.

[17]  C. E. Becker.  The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. , 1984, JAMA.

[18]  J. Shepherd,et al.  Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, Scotland. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[19]  W. Castelli,et al.  The aging thyroid. Thyroid deficiency in the Framingham Study. , 1985, Archives of internal medicine.

[20]  B. Weintraub,et al.  Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. , 1992, The American journal of medicine.

[21]  The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. , 1984, JAMA.

[22]  L. Braverman,et al.  Prevalence of Hypothyroidism and Hashimoto’s Thyroiditis in Two Elderly Populations with Different Dietary Iodine Intake , 1987 .

[23]  B. Biondi,et al.  Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. , 1994, The Journal of clinical endocrinology and metabolism.

[24]  W. Patsch,et al.  Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). , 1995, Metabolism: clinical and experimental.

[25]  J. Shepherd,et al.  The Relationship between Serum Cholesterol and Serum Thyrotropin, Thyroxine and Tri-Iodothyronine Concentrations in Suspected Hypothyroidism , 1990, Annals of clinical biochemistry.

[26]  L A Gavin.  The diagnostic dilemmas of hyperthyroxinemia and hypothyroxinemia. , 1988, Advances in internal medicine.

[27]  M. Caslake,et al.  The composition of low-density lipoprotein and very-low-density lipoprotein subfractions in primary hypothyroidism and the effect of hormone-replacement therapy. , 1979, Clinical science.

[28]  R. Eggertsen,et al.  Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. , 1988, BMJ.

[29]  K. Caidahl,et al.  A DOUBLE‐BLIND CROSS‐OVER 12‐MONTH STUDY OF l‐THYROXINE TREATMENT OF WOMEN WITH ‘SUBCLINICAL’ HYPOTHYROIDISM , 1988, Clinical endocrinology.

[30]  Alan Garber,et al.  CLINICAL GUIDELINE, PART 2: Cholesterol Screening in Asymptomatic Adults, Revisited , 1996, Annals of Internal Medicine.

[31]  T. Friis,et al.  Serum lipids in hyper- and hypothyroidism before and after treatment. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[32]  F. Pazos,et al.  Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. , 1995, The Journal of clinical endocrinology and metabolism.

[33]  E. Livingston,et al.  Prevalence of Thyroid Disease and Abnormal Thyroid Tests in Older Hospitalized and Ambulatory Persons , 1987, Journal of the American Geriatrics Society.

[34]  G. Daniels,et al.  Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. , 1987, The American journal of medicine.

[35]  J Crooks,et al.  Statistical methods applied to the diagnosis of hypothyroidism. , 1969, The Quarterly journal of medicine.

[36]  N. Powe,et al.  Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. , 1996, JAMA.

[37]  B. Biondi,et al.  Cardiac Effects of Long Term Thyrotropin-Suppressive Therapy with Levothyroxine* , 1993 .

[38]  A. Miserez,et al.  Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. , 1997, The Journal of clinical endocrinology and metabolism.

[39]  L. Braverman,et al.  Long-Term L-Thyroxine Therapy Is Associated with Decreased Hip Bone Density in Premenopausal Women , 1989 .

[40]  J. Louvet,et al.  DECREASED HDL CHOLESTEROL IN SUBCLINICAL HYPOTHYROIDISM: THE EFFECT OF L‐THYROXINE THERAPY , 1990, Clinical endocrinology.

[41]  D. Appleton,et al.  LIPID PROFILES AND CARDIOVASCULAR DISEASE IN THE WHICKHAM AREA WITH PARTICULAR REFERENCE TO THYROID FAILURE , 1977, Clinical endocrinology.

[42]  J. Franklyn,et al.  Prevalence and follow‐up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom , 1991, Clinical endocrinology.

[43]  W. Patsch,et al.  Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. , 1990, Archives of internal medicine.

[44]  M. Taskinen,et al.  Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. , 1988, The Journal of clinical endocrinology and metabolism.

[45]  R. D'Agostino,et al.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.

[46]  H. Arntz,et al.  Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified. , 1993, Acta endocrinologica.

[47]  H. Lithell,et al.  Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein‐lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy , 1981, European journal of clinical investigation.

[48]  C. Bloss,et al.  The Oklahoma State Health Department Mobile Multiphasic Screening Program for Chronic Disease. I. , 1966, American journal of public health and the nation's health.

[49]  G. H. White,et al.  CAN THE INITIAL CLINICAL ASSESSMENT OF THYROID FUNCTION BE IMPROVED? , 1978, The Lancet.

[50]  D. Appleton,et al.  THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY , 1977, Clinical endocrinology.